- Home
- AZN vs WFC Comparison
AZN vs WFC Comparison
Compare AZN & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AZN | WFC |
|---|---|---|
| Founded | 1992 | 1852 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.7B | 290.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AZN | WFC |
|---|---|---|
| Price | $195.03 | $78.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | N/A | ★ $97.37 |
| AVG Volume (30 Days) | 2.1M | ★ 14.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 1.65% | ★ 2.24% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.13 | $11.46 |
| Revenue Next Year | $6.21 | $4.55 |
| P/E Ratio | $31.91 | ★ $14.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.24 | $58.42 |
| 52 Week High | $212.71 | $97.76 |
Technical Indicators
Market Signals| Indicator | AZN | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 61.95 | 32.33 |
| Support Level | $89.28 | $77.38 |
| Resistance Level | $211.32 | $85.22 |
| Average True Range (ATR) | 3.38 | 2.79 |
| MACD | -5.22 | -0.61 |
| Stochastic Oscillator | 20.00 | 16.19 |
Price Performance
Historical ComparisonAbout AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $2.1 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.